Search results for: 'Radar Support Frost Radar: Low-Code Application Platforms'
- Related search terms
- frost amp sullivan's accountsignout helpcontactsitemap healthcare home research events blog forum peerconnect tags switch community
- frost amp sullivan believes that global nsps are investing between 50 billion and (6(6 billion) annually on their mobile and wireles
- Frost & Sullivan: Global and Chinese Pharmaceutical Market Research Report
- Frost Radar™: Point-of-Care Ultrasound Imaging Technology Ecosystem, 2026
- frost sullivan global ad chinese pharmaceutical market research report
-
11 Dec 2023  |  Asia Pacific  |  Frost Radar
Frost Radar™: Asia-Pacific Contract Research Organizations, 2023
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
More than 6,000 molecules are currently in clinical development across the pharmaceutical research and development (R&D) landscape, with more than 11,000 in the preclinical phase. The industry is witnessing the growth of small- to mid-segment pharma/biotech players making significant contributions to drug discovery and development pipelines. Across...
$4,950.00
Special Price $3,712.50 save 25 %
-
06 Feb 2020  |  Asia Pacific  |  Market Research
Philippine Diabetes Devices Market, Forecast to 2023
Universal Healthcare Coverage will Help Boost the Low Diagnosis Rate of 33% and Unlock Market Potential
Diabetes is a growing concern globally, with more than 425 million people suffering the world over. The Philippines is no exception. It has a high prevalence of diabetes, of about 6% or an estimated 3.8 million diabetics, in 2018. Unfortunately, only about 33% of this population is actually diagnosed, meaning more than two-thirds of those diabetic...
$3,000.00
Special Price $2,250.00 save 25 %
-
06 Feb 2020  |  Asia Pacific  |  Market Research
Indonesian Diabetes Devices Market, Forecast to 2023
Low Diagnosis Rate of 26% Presents Opportunities to Unlock and Tap in to a Large Market
Diabetes is a growing concern, with more than 425 million people suffering the world over. Indonesia is no exception. It has high prevalence, of about 7% or an estimated 10.48 million diabetics in the country in 2018. Unfortunately, only about 26% of this population is actually diagnosed, meaning over two-thirds of those diabetics are diagnosed onl...
$3,000.00
Special Price $2,250.00 save 25 %
-
01 Apr 2019  |  Asia Pacific  |  Market Research
Vietnamese Clinical Laboratories Market, Forecast to 2025
Increase in Universal Health Support for Private Healthcare will Boost Test Volumes in Both Public and Private Sectors
Clinical laboratories are an essential part of the health industry. Approximately 80% of physicians' diagnoses is estimated to be the result of laboratory tests. The constant pressure to reduce healthcare spending is shifting healthcare application in favor of the laboratory, making it a more valuable part of the treatment plan. Vietnam CLT marke...
$1,500.00
Special Price $1,125.00 save 25 %
-
25 Jun 2013  |  Asia Pacific  |  Market Research
Medical Imaging Markets for CT, MRI, and Ultrasound - China
Advancements in Technology are Increasing the Applications of Medical Imaging Devices
The medical imaging market in China has experienced substantial growth, with multinational and local companies competing for higher market share. Medical imaging technology encompasses a wide range of imaging diagnosis methods (computed tomography, magnetic resonance imaging, and ultrasound are the three major market segments). This study presents ...
$6,000.00
Special Price $4,500.00 save 25 %
-
20 Apr 2023  |  Asia Pacific  |  Market Outlook
Asia-Pacific Next-generation Diagnostics Outlook, 2023
The Renewed Focus on Infectious Diseases Outside COVID-9, Oncology, Cardiovascular, Diabetes, and Prenatal Care will Drive Market Growth
The Asia-Pacific next-generation diagnostics market's revenue is projected to decline by 5.0% in 2023, attributed to the reduced demand for COVID-19-related testing. Rapid expansion in non-COVID molecular diagnostics and point-of-care testing (POCT) will not be sufficient to drive the overall recovery of the region. As companies continue to focus o...
$4,950.00
Special Price $3,712.50 save 25 %
-
04 Mar 2019  |  Asia Pacific  |  Market Outlook
Asia-Pacific Healthcare Industry Outlook, 2019
Innovative Companies are Driving the APAC Healthcare Market
The healthcare market in Asia-Pacific (APAC) is expected to grow by 7.2% in 2019 due to the growth of smart hospitals and developments in the home care segment and medical tourism. This, in turn, has increased the demand for technology, innovative healthcare programmes, as well as drugs and medical devices based on advanced technology. Conventional...
$4,950.00
Special Price $3,712.50 save 25 %
-
03 Apr 2018  |  Asia Pacific  |  Market Outlook
Asia-Pacific Healthcare Outlook, 2018
The Year of Digital Innovation in Asia-Pacific
The healthcare industry in Asia-Pacific (APAC) is expected to grow at 12.5% in 2018, making it one of the fastest growing regions in the world, as the global healthcare economy averages an annual growth rate of 4.8%. This positive growth is fuelled by increasing adoption of technology, innovative healthcare access programs, and delivery of care out...
$4,950.00
Special Price $3,712.50 save 25 %
-
20 Apr 2017  |  Asia Pacific  |  Market Research
The Philippines Transformational Healthcare Insights, 2016
Current Trends and Challenges Encountered in the Road to Achieving Universal Healthcare Coverage
The Philippines is a part of the Association of Southeast Asian Nations (ASEAN) community and one of the fastest growing healthcare markets in the region. With regard to healthcare, the Philippine Government has been looking at ways to achieve 100% enrolment to PhilHealth by 2020. One of the means is by mandating all Filipinos to enrol to PhilHealt...
$1,500.00
Special Price $1,125.00 save 25 %
-
10 Jan 2018  |  Asia Pacific  |  Market Research
APAC Biosimilar Market, Forecast 2025
Patent Expiries, Defined Regulatory Pathways, and Escalating Healthcare Costs to Boost Growth
Biosimilars is a massive opportunity; regardless of a slow start, the market will eventually be a huge business. As per Frost & Sullivan’s estimate, biologic drugs worth $70–$80 billion will lose exclusivity in the next 5 years globally and APAC’s contribution would be more than 20%. Countries in the region, such as India, China, and South Korea, o...
$4,950.00
Special Price $3,712.50 save 25 %